The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
1LIFE HEALTHCARE INC | COM | 68269G107 | 1,821 | 106,200 | SH | SOLE | 106,200 | 0 | 0 | ||
ABCELLERA BIOLOGICS INC | COM | 00288U106 | 856 | 86,504 | SH | SOLE | 86,504 | 0 | 0 | ||
ADC THERAPEUTICS SA | SHS | H0036K147 | 1,194 | 247,630 | SH | SOLE | 247,630 | 0 | 0 | ||
ALBIREO PHARMA INC | COM | 01345P106 | 9,510 | 491,244 | SH | SOLE | 491,244 | 0 | 0 | ||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 6,466 | 1,210,800 | SH | SOLE | 1,210,800 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 11,213 | 502,150 | SH | SOLE | 502,150 | 0 | 0 | ||
ARDELYX INC | COM | 039697107 | 1,340 | 1,126,127 | SH | SOLE | 1,126,127 | 0 | 0 | ||
AVANTOR INC | COM | 05352A100 | 2,404 | 122,668 | SH | SOLE | 122,668 | 0 | 0 | ||
BAXTER INTL INC | COM | 071813109 | 2,101 | 39,000 | SH | SOLE | 39,000 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 1,434 | 113,800 | SH | SOLE | 113,800 | 0 | 0 | ||
CASSAVA SCIENCES INC | PUT | 14817C957 | 1,501 | 35,900 | SH | Put | SOLE | 35,900 | 0 | 0 | |
CHARLES RIV LABS INTL INC | COM | 159864107 | 6,538 | 33,220 | SH | SOLE | 33,220 | 0 | 0 | ||
CUE BIOPHARMA INC | COM | 22978P106 | 3,447 | 1,545,573 | SH | SOLE | 1,545,573 | 0 | 0 | ||
EVOLUS INC | COM | 30052C107 | 1,290 | 160,200 | SH | SOLE | 160,200 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 17,269 | 405,000 | SH | SOLE | 405,000 | 0 | 0 | ||
GRAPHITE BIO INC | COM | 38870X104 | 1,130 | 356,445 | SH | SOLE | 356,445 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 18,753 | 303,000 | SH | SOLE | 303,000 | 0 | 0 | ||
HUMANA INC | COM | 444859102 | 6,210 | 12,800 | SH | SOLE | 12,800 | 0 | 0 | ||
INCYTE CORP | COM | 45337C102 | 2,696 | 40,450 | SH | SOLE | 40,450 | 0 | 0 | ||
JOHNSON & JOHNSON | COM | 478160104 | 5,179 | 31,704 | SH | SOLE | 31,704 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 7,691 | 530,062 | SH | SOLE | 530,062 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 11,433 | 1,327,899 | SH | SOLE | 1,327,899 | 0 | 0 | ||
MARAVAI LIFESCIENCES HLDGS I | COM CL A | 56600D107 | 218 | 8,540 | SH | SOLE | 8,540 | 0 | 0 | ||
MEIRAGTX HLDGS PLC | COM | G59665102 | 9,279 | 1,103,365 | SH | SOLE | 1,103,365 | 0 | 0 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 5,988 | 285,000 | SH | SOLE | 285,000 | 0 | 0 | ||
OMNICELL COM | COM | 68213N109 | 2,672 | 30,700 | SH | SOLE | 30,700 | 0 | 0 | ||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 2,996 | 936,334 | SH | SOLE | 936,334 | 0 | 0 | ||
PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 1,277 | 1,716,290 | SH | SOLE | 1,716,290 | 0 | 0 | ||
PROTHENA CORP PLC | CALL | G72800908 | 3,219 | 53,100 | SH | Call | SOLE | 53,100 | 0 | 0 | |
PROTHENA CORP PLC | SHS | G72800108 | 19,468 | 321,093 | SH | SOLE | 321,093 | 0 | 0 | ||
QUIDELORTHO CORP | COM | 219798105 | 4,496 | 62,900 | SH | SOLE | 62,900 | 0 | 0 | ||
R1 RCM INC | COM | 77634L105 | 595 | 32,113 | SH | SOLE | 32,113 | 0 | 0 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 1,960 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 3,192 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SHATTUCK LABS INC | COM | 82024L103 | 3,026 | 1,120,776 | SH | SOLE | 1,120,776 | 0 | 0 | ||
SILVERBACK THERAPEUTICS INC | COM | 82835W108 | 1,036 | 196,257 | SH | SOLE | 196,257 | 0 | 0 | ||
SPOK HLDGS INC | COM | 84863T106 | 497 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
TENET HEALTHCARE CORP | COM NEW | 88033G407 | 5,261 | 102,000 | SH | SOLE | 102,000 | 0 | 0 |